RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Focus Groups Exploring Experiences with and Preferences for Oral Anticoagulants in People with Nonvalvular Atrial Fibrillation
Barrett, A., DiBenedetti, D., Phatak, H., Masseria, C., & Kamble, S. (2016). Focus Groups Exploring Experiences with and Preferences for Oral Anticoagulants in People with Nonvalvular Atrial Fibrillation. Value in Health, 19(3), A51. https://doi.org/10.1016/j.jval.2016.03.168
Established OAC users reported being satisfied and perceived their OAC as effective with low bleeding risk. Users who switched from warfarin to a NOAC reported increased satisfaction related to the lack of clotting-time testing and no dietary restrictions. All OAC users reported dissatisfaction related to worry about bleeding risk.
